{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-26-001190","form_type":"8-K","ticker":"VANI","cik":"0001266806","company_name":"Vivani Medical, Inc.","filed_at":"2026-07-16T12:30:30+00:00","discovered_at":"2026-07-16T12:35:00.328743+00:00","generated_at":"2026-07-16T12:35:08.878537+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Vivani Medical expects first dosing of SLIM-1 in August 2026","bullets":["CEO Dr. Adam Mendelsohn presented at Emerging Growth Conference on July 15, 2026.","First dosing of SLIM-1 clinical trial now expected in August 2026.","Slide presentation used at conference attached as Exhibit 99.1.","No other material financial or operational updates disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-26-001190","json":"https://secwatch.observer/filing/0001753926-26-001190.json","markdown":"https://secwatch.observer/filing/0001753926-26-001190.md","text":"https://secwatch.observer/filing/0001753926-26-001190.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1266806/000175392626001190/0001753926-26-001190-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1266806/000175392626001190/vani-20260715.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-16T12:35:08.878537+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}